Advertisement
Advertisement
MD
Pediatrix Medical Group, Inc.
23.51
USDSponsored
+0.58
+2.53%
May 08, 16:00 UTC -4
Closed
After-Market
23.50
-0.01
-0.02%
MD Earnings Reports
Positive Surprise Ratio
MD beat 17 of 41 last estimates.
41%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$489.64M
/$0.60
Implied change from Q1 26 (Revenue/ EPS)
+2.82%
/+36.36%
Implied change from Q2 25 (Revenue/ EPS)
+4.44%
/+13.21%
Pediatrix Medical Group, Inc. earnings per share and revenue
On May 05, 2026, MD reported earnings of 0.44 USD per share (EPS) for Q1 26, beating the estimate of 0.38 USD, resulting in a 12.88% surprise. Revenue reached 476.20 million, compared to an expected 479.80 million, with a -0.75% difference. The market reacted with a -7.05% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of 0.60 USD, with revenue projected to reach 489.64 million USD, implying an increase of 36.36% EPS, and increase of 2.82% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
FAQ
What were Pediatrix Medical Group, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Pediatrix Medical Group, Inc. reported EPS of $0.44, beating estimates by 12.88%, and revenue of $476.20M, -0.75% below expectations.
How did the market react to Pediatrix Medical Group, Inc.'s Q1 2026 earnings?
The stock price moved down -7.05%, changed from $22.41 before the earnings release to $20.83 the day after.
When is Pediatrix Medical Group, Inc. expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Pediatrix Medical Group, Inc.'s next earnings report?
Based on 9
analysts, Pediatrix Medical Group, Inc. is expected to report EPS of $0.60 and revenue of $489.64M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement